Saventic Health sp. z o.o.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2018-11-21
Share capital
41,850.00 PLN
Activity description

Saventic Health is a company that utilizes AI-driven technology to streamline clinical trials, diagnostics, and treatment pathways for rare diseases. It provides tools to identify high-risk patients faster and more accurately, facilitating recruitment for clinical studies and improving patient outcomes. Additionally, Saventic Health offers integration with hospital EMRs and a global online application for patients and caregivers to manage the patient journey.

Registered address
ul. Władysława Łokietka 5, 87-100 Toruń, Poland
Email
Social media
Electronic delivery address
AE:PL-14173-63033-SJTDT-25

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 86 days late).

  • 202501/07/2026
  • 202418/06/2025
  • 202318/06/2024
  • 202214/07/2023
  • 202109/10/2022
  • 202030/09/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 15%
City · Toruń643 / 2,418
Top 27%
Voivodeship · Kujawsko-Pomorskie3,579 / 11,436
Top 31%
Country · Poland86,907 / 297,069
Top 29%

Results vs industry

Revenue
This companyUSD 1.09mMedianUSD 73.13kAverageUSD 3.24m
Net profit
This companyUSD -586.89kMedianUSD 69.70AverageUSD 83.06k
Operating costs
This companyUSD 1.65mMedianUSD 75.83kAverageUSD 3.05m
Assets
This companyUSD 2.47mMedianUSD 120.25kAverageUSD 3.90m

Offer

Websites

The company has 5 websites, including 2 versions for foreign markets (e.g. Germany, Brazil). Most of them run on WordPress. The sites are available in: Polish, English, German, French, Spanish and 7 more. The company uses the Meta advertising pixel (Facebook, Instagram).

  • saventic.comSaventic Health: Find patients with rare diseases 6x faster
    WordPress 7.1ElementorYoast SEOWPMLNginx
  • bloodlab.plInterpretacja wyników badań laboratoryjnych online, wyniki badań – analiza, znaczenie | Bloodlab
    Google Tag ManagerMeta PixelNginx
  • saventiccare.comSaventic Care – Your AI Partner in Rare Disease Diagnosis
    WordPress 7.1ElementorGoogle Tag ManagerYoast SEOWPMLCloudflare

Authorized Representatives

Szymon Piotr Piątkowski age 46 – President of the Management Board

Manner of representation

The following are authorised to submit declarations concerning the company's property rights and obligations and to sign on behalf of the company: A. in the case of a multi-member management board: two members of the management board acting jointly always with the President of the Management Board, if appointed, and the Vice-President of the Management Board, if appointed; B. in the case of a one-person management board: one member of the management board independently.

Supervisory board

Marcin Andrzej Molo age 53 – Supervisory Board Member
Artur Kluź age 51 – Supervisory Board Member
Tomasz Paweł Biłous age 51 – Supervisory Board Member

Ownership

OwnerSharesShare valueStake
132$1,782.8215.7706%
141$1,904.3816.8459%
Karol Lis age 39
111$1,499.1913.2616%
108$1,458.6712.9032%
225$3,038.9026.8817%
Others
120$1,620.7514.337%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2018-12-01.

  • mBank
    74 1140 1010 0000 4868 7600 1001
  • mBank
    47 1140 1010 0000 4868 7600 1002

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

Publication dateEvent
Jul 5, 2024Call to creditors

Public aid

14 public aid cases recorded, with a total value of $2,175,671.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$394
De minimis aid (in accordance with Commission Regulation 2023/2831)
$696
De minimis aid (in accordance with Commission Regulation 2023/2831)
$691

European Funds

ProjectEU co-financing
Development of an innovative algorithmic engine using artificial intelligence and new knowledge derived from a large set of real-world medical data to support physicians in the earlier detection and treatment of iron deficiencies based on blood count results and other diagnostic tests.
$1M
Development of a support engine that uses advanced artificial intelligence methods and machine capacity to process millions of patient records in a sufficiently short time to detect the risk of rheumatic diseases early, thereby supporting the diagnostic process performed by a physician.
$754K
Development and implementation of an innovative machine-learning-based diagnostic process to shorten the patient pathway and improve the quality of healthcare for patients with lympho- and myeloproliferative diseases.
$344.7K

Competitors

Name
Proacta S.A.
Upside Lab sp. z o.o.
Medplace.Pl sp. z o.o.
Alcid sp. z o.o.
Gradis sp. z o.o.
Mindz It sp. z o.o. + limited partnership
Nivalit sp. z o.o.
Precisionlife Poland sp. z o.o.
Inovintell sp. z o.o.
Lifestyle-Med sp. z o.o.

Change history

DateEvent
2025-12-09Share capital increase
2025-03-17Share capital increase
2025-01-16Share capital increase
2024-10-31Share capital increase
2024-10-16Share capital reduction

FAQ

Last updated: 2026-07-09